Loading company…
Qpex Biopharma, based in San Diego, develops anti-infective therapies that target antimicrobial resistance in bacterial and fungal pathogens.
Founded in 2018 and headquartered in San Diego, US, Qpex Biopharma develops anti-infectives for infections caused by resistant pathogens, with products aimed at healthcare institutions and partners. Founder and CEO Michael Dudley leads the company, which has raised USD 100.00 mn across 2 deals. In June 2023 it agreed a trade sale with SHIONOGI & CO., LTD. for USD 140 mn, including USD 100 mn upfront and USD 40 mn tied to milestones, with closing expected by July 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in